Clinical Trials on HER2 阳性乳腺癌幸存者 in United States
总计6103个结果
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research Foundation主动,不招人
-
Dana-Farber Cancer InstituteConquer Cancer Foundation招聘中
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.终止
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的乳腺癌 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | HER2 阴性乳腺癌美国
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCare主动,不招人
-
Seagen Inc.完全的
-
OmicsWay Corp.Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary of Karelia Republic...主动,不招人
-
University of Kansas Medical CenterPfizer终止
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of Defense主动,不招人
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.招聘中
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.招聘中
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey终止
-
National Cancer Institute (NCI)完全的
-
University of NebraskaNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu 阴性 | HER2/Neu阳性 | 孕激素受体阴性 | 孕激素受体阳性 | 三阴性乳腺癌 | III期乳腺癌美国
-
Criterium, Inc.Novartis; Seagen Inc.招聘中
-
Sun Pharma Advanced Research Company Limited终止
-
Bolt Biotherapeutics, Inc.Hoffmann-La Roche主动,不招人
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals NHS Trust招聘中
-
Bavarian Nordic主动,不招人
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer Research; Susan G.... 和其他合作者招聘中
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity Inc主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin Ireland完全的
-
University of WashingtonNational Cancer Institute (NCI)完全的HER2阳性乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌美国
-
University of MiamiNational Cancer Institute (NCI)尚未招聘
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Memorial Sloan Kettering Cancer Center招聘中乳腺癌 | HER2阳性乳腺癌 | 心脏毒性 | 乳腺癌第四期 | 乳腺癌一期 | 乳腺癌二期 | 乳腺癌三期 | HER2阳性转移性乳腺癌美国
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline完全的HER2-Positive Early Stage Breast Cancer美国
-
BeiGene招聘中晚期乳腺癌 | 转移性乳腺癌 | 晚期实体瘤 | 非小细胞肺癌 | 激素受体阳性乳腺恶性肿瘤 | 激素受体阳性乳腺癌 | HER2 阴性乳腺癌 | 激素受体阳性 HER-2 阴性乳腺癌 | 激素受体阳性乳腺癌澳大利亚, 美国
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
Abramson Cancer Center at Penn Medicine招聘中
-
Atossa Therapeutics, Inc.InClin招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | HER2阳性乳腺癌美国
-
Emory UniversityNovartis终止IV 期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | HER2 阴性乳腺癌美国
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer Research Consortium 和其他合作者招聘中
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead Sciences主动,不招人转移性乳腺癌 | 浸润性乳腺癌 | HER2 阴性乳腺癌 | HR 阳性乳腺癌美国
-
University of Wisconsin, MadisonContext Therapeutics Inc.终止
-
Novartis Pharmaceuticals完全的
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.招聘中
-
Infinity Pharmaceuticals, Inc.终止
-
Washington University School of MedicineNational Cancer Institute (NCI)终止II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌 | HER2 阴性乳腺癌美国
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast Cancer Research...招聘中
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)终止IV 期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性 | 雌激素受体阳性 | HER2/Neu阳性 | 孕激素受体阴性 | 孕激素受体阳性美国